SCHEMBL6318837

SCHEMBL6318837

Cc1cc(C(CCc2cnc3ccccc3c2)P2(=O)CCCCC2)cc(C)c1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.36
FAAH O00519 6/20 0.36
NOTUM Q6P988 1/20 0.35
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DHODH Q02127 1/20 0.34
CYP1A2 P05177 1/20 0.33
ERCC5 P28715 1/20 0.33
FEN1 P39748 1/20 0.33
MGAM O43451 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318069 0.72 KDR (0.39) KDRNOTUMCYP1A2MGAMMEN1
SCHEMBL6318065 0.69 KMT2A (0.34) KDRNOTUMCYP1A2MGAMMEN1
SCHEMBL6325319 0.67 KDR (0.44) KDRNOTUMHDAC6MEN1KMT2A
SCHEMBL3396692 0.65 CYP1A2 (0.55) DHODHCYP1A2MGAMHDAC3HDAC4
SCHEMBL12328198 0.65 CYP1A2 (0.42) CYP1A2MEN1KMT2A
SCHEMBL6115113 0.63 TRPV1 (0.55) CYP1A2MEN1KMT2A
SCHEMBL5546916 0.63 ALDH1A1 (0.50) FAAHDHODHCYP1A2MGAMHDAC3
SCHEMBL20224978 0.62 CYP1A2 (0.46) CYP1A2MEN1KMT2A
SCHEMBL14193410 0.62 CYP1A2 (0.49) CYP1A2MGAMHDAC3HDAC4HDAC1
SCHEMBL530633 0.62 MGAM (0.49) KDRFAAHDPP4DPP8DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US claimed
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels QUATRX PHARMACEUTICALS CO. 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143349-A1 Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels APOB, LDLR, LPL KDR 2530/4885FAAH 2332/4885NOTUM 3343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.